Dominique N. Lisiero, Ph.D. - Publications

Affiliations: 
2012 Molec & Med Pharmacology 0639 University of California, Los Angeles, Los Angeles, CA 
Area:
Immunology

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lisiero DN, Cheng Z, Tejera MM, Neldner BT, Warrick JW, Wuerzberger-Davis SM, Hoffmann A, Suresh M, Miyamoto S. IκBα Nuclear Export Enables 4-1BB-Induced cRel Activation and IL-2 Production to Promote CD8 T Cell Immunity. Journal of Immunology (Baltimore, Md. : 1950). PMID 32817348 DOI: 10.4049/Jimmunol.2000039  0.347
2014 Lisiero DN, Soto H, Everson RG, Liau LM, Prins RM. The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells. Journal For Immunotherapy of Cancer. 2: 8. PMID 25054063 DOI: 10.1186/2051-1426-2-8  0.404
2014 Everson RG, Jin RM, Wang X, Safaee M, Scharnweber R, Lisiero DN, Soto H, Liau LM, Prins RM. Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients. Journal For Immunotherapy of Cancer. 2: 10. PMID 24883189 DOI: 10.1186/2051-1426-2-10  0.434
2013 Prins RM, Wang X, Soto H, Young E, Lisiero DN, Fong B, Everson R, Yong WH, Lai A, Li G, Cloughesy TF, Liau LM. Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 152-7. PMID 23377664 DOI: 10.1097/Cji.0B013E3182811Ae4  0.378
2012 Fong B, Jin R, Wang X, Safaee M, Lisiero DN, Yang I, Li G, Liau LM, Prins RM. Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients. Plos One. 7: e32614. PMID 22485134 DOI: 10.1371/Journal.Pone.0032614  0.416
2011 Lisiero DN, Soto H, Liau LM, Prins RM. Enhanced sensitivity to IL-2 signaling regulates the clinical responsiveness of IL-12-primed CD8(+) T cells in a melanoma model. Journal of Immunology (Baltimore, Md. : 1950). 186: 5068-77. PMID 21430221 DOI: 10.4049/Jimmunol.1003317  0.378
Show low-probability matches.